Promis Neurosciences Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Promis Neurosciences Inc with three other
miscellaneous service companies in North America:
Quest PharmaTech Inc
(2017
sales of 2,569.00 Canadian Dollars [US$2,013.33 ]
),
Co-Diagnostics Inc
of the United States
($7,662.00
of which 100%
was Medical Instrument), and
Cell MedX Corp
which is
also
based in the United States
($6,220.00
).
Sales Analysis.
Sales increased substantially in 2017:
Promis Neurosciences Inc reported sales of C$9,895.00 (US$7.75 thousand)
for the
year ending
December of 2017.
This
represents
an
increase of 267.7%
versus 2016, when the company's sales were C$2,691.00 .
Despite this increase, sales are still
well
below the level achieved in 2015, when Promis Neurosciences Inc
reported sales of C$19,935.00 .